HZNP(Delisted)
Horizon Therapeutics Public·NASDAQ
--
--(--)
HZNP Profile
Horizon Therapeutics Public Limited Company
A company that developing therapeutics for the treatment of rare and rheumatic diseases
70 St. Stephen’s Green, Dublin 2, D02 E2X4, Ireland
--
Horizon Therapeutics Public Limited Company is a specialized pharmaceutical company specializing in DUEXIS, VIMOVO and RAYOS/LODOTRA. These drugs are mainly aimed at the treatment of arthritis, pain and inflammatory diseases. The company developed DUEXIS and RAYOS/LODOTRA, and in November 2013, acquired the ownership of VIMOVO in the United States from AstraZeneca. The company's strategy is to develop, obtain patents or licenses for additional innovative drugs, or obtain companies that can acquire specialized targeted physicians (such as primary care physicians, orthopedic physicians and rheumatologists), while leveraging the company's commercial advantages and the infrastructure in place to implement targeted commercial approaches. Horizon Pharma Public Limited Company was incorporated in Delaware on March 23, 2010 and re-incorporated in Ireland.
